## MKC: McCormick & Company, Incorporat - XLP: Consumer Defensive

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 4.5% in mid entry zone (3.0-6.0%), top quartile (80th pct) cross-sectional ranking. Short-term MRS_5 (4.4%) confirms momentum alignment. Strong momentum (+8.4% 5-day acceleration). Outperforming sector by 3.2%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($64.10)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 9
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Benjamin Edwards Inc. Raises Stock Holdings in McCormick & Company, Incorporated $MKC**
- Source: MarketBeat | 20251213T120821 | Somewhat-Bullish | Relevance: 100%
- Benjamin Edwards Inc. increased its stake in McCormick & Company, Incorporated by 8.7% in Q2, acquiring an additional 47,460 shares and bringing its total holdings to 595,233 shares valued at approximately $45.13 million. Despite this, company insiders have been net sellers, with CEO Brendan M. Foley and Lawrence Erik Kurzius selling significant shares, resulting in insiders selling 146,158 shares within the last 90 days. McCormick & Company also recently beat its quarterly earnings estimates, provided optimistic FY2025 EPS guidance, and raised its quarterly dividend.

**2. State Street Corp Decreases Position in McCormick & Company, Incorporated $MKC**
- Source: MarketBeat | 20251212T101833 | Neutral | Relevance: 100%
- State Street Corp significantly reduced its stake in McCormick & Company, Incorporated ($MKC) by 2.9% in the second quarter, selling over 438,000 shares. Despite this, they still own a substantial 5.51% of the company, valued at over $1.1 billion. The article also details other institutional investor activities, recent analyst ratings, insider trading (including sales by the CEO and a major shareholder), and McCormick's latest financial performance and dividend increase.

**3. Bernstein Adjusts McCormick Price Target to $87 From $91, Maintains Outperform Rating**
- Source: marketscreener.com | 20251211T140942 | Somewhat-Bullish | Relevance: 100%
- Bernstein has lowered its price target for McCormick & Company (MKC) from $91 to $87, while reiterating an Outperform rating on the stock. This adjustment reflects an updated valuation outlook for the food processing company. McCormick & Company specializes in manufacturing and marketing aromatic products and recently increased its quarterly dividend.

**4. Intact Investment Management Inc. Takes $4.99 Million Position in McCormick & Company, Incorporated $MKC**
- Source: MarketBeat | 20251211T120942 | Somewhat-Bullish | Relevance: 100%
- Intact Investment Management Inc. recently acquired a new stake of 65,800 shares in McCormick & Company, Incorporated (NYSE:MKC) worth approximately $4.99 million in the second quarter. This move comes amidst significant insider selling from McCormick executives, with CEO Brendan Foley reducing his holdings by over 34%. Despite these insider sales, analysts have a consensus "Hold" rating for MKC with a price target of $78.22, and the company recently increased its quarterly dividend to $0.48 per share.

**5. How Is McCormickâ€™s Stock Performance Compared to Other Food & Beverage Stocks?**
- Source: Markets Financial Content | 20251211T031013 | Somewhat-Bearish | Relevance: 100%
- McCormick & Company's stock (MKC) has underperformed compared to the First Trust Nasdaq Food & Beverage ETF (FTXG) and its peer Hormel Foods (HRL) over the past year, despite reporting better-than-expected Q3 financials. The stock is currently trading significantly below its two-year high and its moving averages indicate a bearish trend. Analysts, however, maintain a "Moderate Buy" rating with a substantial upside potential.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 14 ($0.03M) |
| Sells | 3 ($3.72M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 2 |

**Top Holders:**
- Vanguard Group Inc: 12.8% (-0.2%)
- Blackrock Inc.: 7.8% (+1.2%)
- State Farm Mutual Au: 6.5% (0.0%)
- State Street Corpora: 6.1% (+5.1%)
- Geode Capital Manage: 2.5% (+1.1%)

### Key Risks

1. Insider selling cluster: $3.7M in recent transactions.
2. Long-term trend broken: trading 6.9% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +8.4% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.87 signals overvaluation risk, limited margin of safety. Forward P/E 20.8x stretched relative to 6% growth. Insider selling cluster ($3.7M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $17.9B |
| Beta | 0.62 |
| 52W Range | $62.64 - $86.24 |
| Short Interest | 0.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.87 |
| Forward P/E | 20.8 |
| Current P/E | 22.1 |
| YoY Growth | 6.3% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -3.9% to 4.5% (+8.4% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (3.0-6.0%), cross-sectional ranking at 80th percentile. MRS_5 at 4.4% confirms short-term momentum alignment. Outperforming sector by 3.2pp, stock-specific strength. Below SMA200 (0.93x), long-term trend not supportive. RSI neutral at 57. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 4.53% (CS: 81) | Strong |
| RSI_14 | 56.9 | Neutral |
| MACD Histogram | 0.05 | Bullish |
| vs SMA20 | 1.017x | Above |
| vs SMA50 | 1.015x | Above |
| vs SMA200 | 0.931x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $66.80
- **Stop Loss:** $64.10 (4.0% risk)
- **Target:** $70.85 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 444
- **Position Value:** $29,659.20
- **Portfolio %:** 29.66%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-01-29 (Est: $0.87)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.82 | $0.85 | +4.2% |
| 2025Q2 | $0.65 | $0.69 | +5.7% |
| 2025Q1 | $0.64 | $0.60 | -6.9% |
| 2024Q4 | $0.77 | $0.80 | +4.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*